HIV infection and lung function decline: Challenges, clinical implications, and new questions

AIDS

Volumn 27, Issue 8, 2013, Pages 1345-1347

  Crothers, Kristina ^a   Morris, Alison ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

HIV; Lung Disease; Lung function; Obstructive; Respiratory tract disease

Indexed keywords

BRONCHODILATING AGENT; CD4 ANTIGEN;

CD4 LYMPHOCYTE COUNT; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG USE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG FUNCTION; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; RISK FACTOR; SMOKING; SPIROMETRY;

FEMALE; HIV INFECTIONS; HUMANS; LUNG; LUNG DISEASES, OBSTRUCTIVE; MALE; RESPIRATORY TRACT DISEASES;

EID: 84879121822     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283601082     Document Type: Review

References (19)

1. Murray JF, Mills J. Pulmonary infectious complications of human immunodeficiency virus infection. Part II. Am Rev Respir Dis 1990; 141:1582-1598.
2. Murray JF, Mills J. Pulmonary infectious complications of human immunodeficiency virus infection. Part I. Am Rev Respir Dis 1990; 141:1356-1372.
3. Wallace JM, Hansen NI, Lavange L, Glassroth J., Browdy BL, Rosen MJ, et al Respiratory disease trends in the Pulmonary Complications of HIV Infection Study cohort. Am J Respir Crit Care Med 1997; 155:72-80.
4. Crothers K, Huang L, Goulet J.L., Goetz MB, Brown ST, Rodriguez-Barradas MC, et al HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. Am J Respir Crit Care Med 2011; 183:388-395.
5. Kirk GD, Merlo C, O'Driscoll P, Mehta SH, Galai N, Vlahov D, et al. HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clin Infect Dis 2007; 45:103-110.
6. Drummond MB, Kirk GD, Astemborski J, Marshall M.M., Mehta SH, McDyer JF, et al Association between obstructive lung disease and markers of HIV infection in a high-risk cohort. Thorax 2012; 67:309-314.
7. Almodovar S, Hsue PY, Morelli J, Huang L., Flores SC Patho-genesis of HIV-associated pulmonary hypertension: potential role of HIV-1 Nef. Proc Am Thorac Soc 2011; 8:308-312.
8. Madeddu G, Fois AG, Calia G.M., Babudieri S., Soddu V, Becciu F, et al Chronic obstructive pulmonary disease: an emerging comorbidity in HIV-infected patients in the HAART era? Infection 2012. [Epub ahead of print]
9. Gingo MR, George MP, Kessinger C.J., Lucht L., Rissler B, Weinman R, et al Pulmonary function abnormalities in HIV-infected patients during the current antiretroviral therapy era. Am J Respir Crit Care Med 2010; 182:790-796.
10. Lopez AD, Shibuya K, Rao C., Mathers CD, Hansell AL, Held LS, et al Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 2006; 27:397-412.
11. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD); 2011. http://www.goldcopd.org/ [Accessed 11 march 2013].
12. Justice AC, Lasky E, McGinnis K.A., Skanderson M., Conigliaro J, Fultz SL, et al Medical disease and alcohol use among veterans with human immunodeficiency infection: a comparison of disease measurement strategies. Med Care 2006; 44:S52-S60.
13. Drummond MB, Merlo CA, Astemborski J, Kalmin M.M., Kisalu A., Mcdyer JF, et al The effect of HIV infection on longitudinal lung function decline among IDUs: a prospective cohort. AIDS 2013; 27:1303-1311.
14. George MP, Kannass M, Huang L., Sciurba FC, Morris A. Respiratory symptoms and airway obstruction in HIV-infected subjects in the HAART era. PLoS One 2009; 4:e6328.
15. Morris A, Sciurba FC, Lebedeva I.P., Githaiga A., Elliott WM, Hogg JC, et al Association of chronic obstructive pulmonary disease severity and Pneumocystis colonization. Am J Respir Crit Care Med 2004; 170:408-413.
16. Akgun KM, Gordon K, Pisani M., Fried T, McGinnis KA, Tate J.P., et al. Risk factors for hospitalization and medical intensive care unit (MICU) admission among HIV-infected veterans. J Acquir Immune Defic Syndr 2013; 62:52-59.
17. Powell K, Davis JL, Morris A.M., Chi A., Bensley MR, Huang L. Survival for patients with HIV admitted to the ICU continues to improve in the current era of combination antiretroviral therapy. Chest 2009; 135:11-17.
18. Drummond MB, Kirk GD, McCormack M.C., Marshall MM, Ricketts EP, Mehta SH, et al HIV and COPD: impact of risk behaviors and diseases on quality of life. Qual Life Res 2010; 19:1295-1302.
19. Vital signs: current cigarette smoking among adults aged ≥ 18 - years - United States, 2009. MMWR Morb Mortal Wkly Rep 2010; 59:1135-1140.